FDA Takes Action Against Compounded Menopause Hormone Therapy Drugs

		HysterSisters > Site News Articles
FDA Takes Action Against Compounded Menopause Hormone Therapy Drugs

FDA Takes Action Against Compounded Menopause Hormone Therapy Drugs

From the Site News Articles List

HysterSisters Articles

Options to Hysterectomy
Pre-Op Hysterectomy
Post-Op Hysterectomy
Hormone and Menopause
Intimacy after Hysterectomy
Pelvic Floor
Fitness after Hysterectomy
GYN Cancer
Grief and Loss
Endometriosis
Uterine Fibroids
Hysterectomy Stories
Ask A Doctor

January 9, 2008

The U.S. Food and Drug Administration (FDA) sent letters warning seven pharmacy operations that the claims they make about the safety and effectiveness of their so-called "bio-identical hormone replacement therapy," or "BHRT" products are unsupported by medical evidence, and are considered false and misleading by the agency. FDA is concerned that unfounded claims like these mislead women and health care professionals.

The pharmacy operations improperly claim that their drugs, which contain hormones such as estrogen, progesterone, and estriol (which is not a component of an FDA-approved drug and has not been proven safe and effective for any use) are superior to FDA-approved menopausal hormone therapy drugs and prevent or treat serious diseases, including Alzheimer's disease, stroke, and various forms of cancer.

FDA is concerned that the claims for safety, effectiveness, and superiority that these pharmacy operations are making mislead patients, as well as doctors and other health care professionals. Compounded drugs are not reviewed by the FDA for safety and effectiveness, and FDA encourages patients to use FDA-approved drugs whenever possible. The warning letters state that the pharmacy operations violate federal law by making false and misleading claims about their hormone therapy drugs.

"We want to assure that Americans receive accurate information about the risks and benefits of drug therapies," said Dr. Janet Woodcock, FDA's chief medical officer and acting director of the agency's Center for Drug Evaluation and Research. "In addition to today's regulatory action, FDA is publishing an informational article for women on its consumer health information web page that provides the facts to make informed decisions about these unapproved therapies. Women taking these drugs should discuss with their health care providers the drugs' risks and whether they're getting effective treatment."

The pharmacy operations receiving warning letters use the terms "bio-identical hormone replacement therapy" and "BHRT" to imply that their drugs are natural or identical to the hormones made by the body. *FDA regards this use of "bio-identical" as a marketing term implying a benefit for the drug, for which there is no medical or scientific basis.*

The pharmacy operations also make unsupported claims that their drugs are better than FDA-approved menopausal hormone therapy drugs and can be used to prevent and treat serious diseases such as Alzheimer's disease, stroke, and various forms of cancer.

The pharmacy operations compound hormone therapy drugs that contain estriol as well as progesterone and estrogen. No drug product containing estriol has been approved by FDA and the safety and effectiveness of estriol is unknown.

Firms that do not properly address violations identified in warning letters risk further enforcement, including injunctions that prevent additional violations, and seizure of violative drugs.

FDA's action today does not target pharmacists who practice traditional pharmacy compounding and who do not make false or misleading claims about compounded products. Traditional pharmacy compounding typically involves preparation of a drug for an individual patient by a pharmacist in response to a valid prescription from a licensed practitioner. This compounding follows a practitioner's decision that his or her patient has a special medical need that cannot be met by FDA-approved drugs. FDA's current view on human drug compounding is addressed in its compounding Compliance Policy Guide, available at http://www.fda.gov/cder/pharmcomp/default.htm.

FDA also responded today to a citizen petition from Wyeth, Madison, NJ, asking FDA to take regulatory action against compounding pharmacy operations that produce compounded "BHRT" drugs.* Other stakeholders, including health care providers and consumer groups, have also raised concerns about "BHRT" drugs.

All patients who use compounded hormone therapy drugs should discuss menopausal hormone therapy options with their health care provider to determine if compounded drugs are the best option for their specific medical needs. If patients or practitioners encounter problems with compounded hormone therapy drugs, they are encouraged to file a MedWatch report with the FDA at www.fda.gov/medwatch or by phone at 1-800-FDA-1088.

For more information, see a consumer article called Bio-Identicals: Sorting Myths from Facts http://www.fda.gov/consumer/updates/...als010908.html.

Warning Letters and Q and A's are available at http://www.fda.gov/cder/pharmcomp/default.htm.

For HysterSisters Discussion of this press release: Click Here

Printer Friendly Version

Related Titles

Recommended for Hysterectomy Recovery

The HysterSisters Store has gathered products made specifically for your recovery from surgery. Here are the best sellers we can recommend to help you:

The Great Binder Set - We have made it very easy for you and combined the two best binders and the Silky Sac into a great set to save you money! Our favorite is the Perfect Pocket binder with cold/hot packs!
Deluxe Hyst Prep Set - As you plan, we've gathered the best products into one set for special pricing.
Post-Op Panty - These great panties speed recovery, and reduces scarring. They contain a medical-grade silicone panel over incision to reduce scar's apperance while they provide support to weakened muscles and tissues from surgery. Excellent!
Softest Bra Ever - When you want to wear something, but feel nothing. This is the softest bra ever, in microfiber with no hardware or tags to chafe or dig! The comfort-ribbed underband stays in place gently, so it is perfect for sleeping and lounging.
HysterSisters Accessory Kit - Are you a HysterSisters fan? This set has a fun collection of HysterSisters items.
Very Private Moisture - Once your doctor gives you the green light for intimacy, this is the stuff! This is a best selling product with a high rate of permanent, satisfied, repeat customers! Relieves vaginal dryness instantly, protects tissue & enhances intimacy. "Buy it for the problem, use it for the pleasure."

FDA Asserts New Policy to Restrict Women’s Access to Bioidentical Hormones

February News- HysterSisters Checking In

Find A Doctor Near You

Arnold Advincula, M.D. Florida Hospital Celebration Health 400 Celebration Place Celebration FL 34747 (407) 303-4573	Ruslana Kadze, M.D. 5525 Etiwanda Avenue Suite 228 Tarzana (Los Angeles) CA 91356 818-343-1717	Jack Ayoub, M.D. 44035 Riverside Parkway Suite 435 Leesburg VA 20176 703.858.5599
Gretchen Makai, M.D. 4735 Ogletown Stanton Rd MAP II, Ste 2103 Christiana Care Health System Newark DE 19713 302-623-4410	Richard W Farnam, M.D. 1700 N. Oregon Suite 520 El Paso TX 79902 9155335600	David Newman, M.D. 10030 Edison Square Drive, Suite 100A Concord NC 28027 704-403-7670
Mark Richey, M.D. 1200 Airport Heights Ste 205 Anchorage AK 99508 9072724443	Terry Grogg, M.D. 4461 S Broadway Suite 200 Suite 200 Grove City OH 43123 614-875-0444	David Mainman, M.D. Desert Bloom Obstetrics & Gynecology 6452 E. Carondelet Drive, Suite A Tucson AZ 85710 520-885-5300

Receive support and resources for your hysterectomy related needs: